Cochlear Limited (CHEOY)

76.75 +1.71 (+2.28%) At close: 03:50PM EDT

Cochlear Limited

1 University Avenue
Macquarie University
Sydney, NSW 2109
Australia
61 2 9428 6555
https://www.cochlear.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 4,500

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Diggory William Howitt BE (Hons), MBA	CEO, MD, Pres & Exec. Director	2.69M	241.05k	1967
Mr. Stuart Sayers	Chief Financial Officer	1.02M	N/A	N/A
Mr. Jan Janssen MSc Elec Eng	Chief Technology Officer	1.13M	35.04k	1965
Mr. Anthony Bishop	Pres of Asia Pacific & Latin America	848.36k	10.72k	N/A
Ms. Lisa Aubert	Pres of North America	673.9k	N/A	N/A
Mr. Richard Brook MBA	Pres of EMEA	1.26M	30.64k	N/A
Ms. Kristina Devon	VP of Investor Relations	N/A	N/A	N/A
Ms. Jennifer Stevenson	VP of Corp. Communications & Brand	N/A	N/A	N/A
Mr. Dean Phizacklea	Sr. VP of Global Strategic Marketing	N/A	N/A	N/A
Ms. Jennifer Hornery	Sr. VP of Global People & Culture	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.

Corporate governance

Cochlear Limited’s ISS governance QualityScore as of 1 February 2023 is 1. The pillar scores are Audit: 1; Board: 5; Shareholder rights: 6; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.